LWAC · Categories · Form 4

LWAC - SEC Form 4 insider transactions

LightWave Acquisition Corp. (LWAC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LWAC

• 1661d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1661d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1661d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1661d
  SEC Form 4 filed by Root Jonathan D

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1661d
  SEC Form 4 filed by Lasky Laurence

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1661d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Root Jonathan D was granted 4,822,114 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Ehrlich Christopher B converted options into 143,202 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Bhatt Elizabeth converted options into 9,047 units of Class A Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Gallagher Brian M. Jr. was granted 4,822,114 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Locust Walk Sponsor, Llc converted options into 3,511,250 units of Common Stock, increasing direct ownership by 644% to 4,056,250 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Smither John W was granted 24,142 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4 filed by Patel Premal

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Mcnulty Alana B. was granted 48,768 units of Common Stock

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1703d
  SEC Form 4: Worland Stephen T was granted 755,480 units of Common Stock, increasing direct ownership by 34% to 755,480 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)

Other LWAC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends